Cargando…

Humoral Response Following Triple Dose of mRNA Vaccines Against SARS-CoV-2 in Hemodialysis Patients: Results After 1 Year of Follow-Up

INTRODUCTION: COVID-19 is associated with an increased mortality in hemodialysis patients. Therefore, achieving a long-lasting effective immune response to SARS-CoV-2 vaccines is essential. This study describes the humoral immune response in hemodialysis patients following three doses of mRNA vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gallego-Valcarce, Eduardo, Shabaka, Amir, Leon-Poo, Mariana, Gruss, Enrique, Acedo-Sanz, Juan Manuel, Cordón, Alfredo, Cases-Corona, Clara, Fernandez-Juarez, Gema
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314744/ https://www.ncbi.nlm.nih.gov/pubmed/35903310 http://dx.doi.org/10.3389/fmed.2022.927546

Ejemplares similares

Late thrombotic complications after SARS‐CoV‐2 infection in hemodialysis patients
por: Shabaka, Amir, et al.
Publicado: (2021)

Therapeutic Insights in Chronic Kidney Disease Progression
por: Shabaka, Amir, et al.
Publicado: (2021)

Recurrent acute interstitial nephritis: what lies beneath
por: Caravaca-Fontán, Fernando, et al.
Publicado: (2020)

SARS-CoV-2 mRNA Vaccine-Induced Cellular and Humoral Immunity in Hemodialysis Patients
por: Kwiatkowska, Ewa, et al.
Publicado: (2022)

Changing trends in presentation and indications of biopsy in lupus nephritis: data from the Spanish Registry of Glomerulonephritis
por: Shabaka, Amir, et al.
Publicado: (2021)

Humoral Response in Hemodialysis Patients Following COVID-19 Vaccination and Breakthrough Infections during Delta and Omicron Variant Predominance
por: Chinnadurai, Rajkumar, et al.
Publicado: (2022)

Humoral profiles of toddlers and young children following SARS-CoV-2 mRNA vaccination
por: Nziza, Nadège, et al.
Publicado: (2023)

Absence of Antibody Reponses and Severe COVID-19 in Patients on Hemodialysis Following mRNA Vaccination
por: Michael, Miriam B, et al.
Publicado: (2021)

Acute kidney failure and nephrotic syndrome secondary to COVID-19-associated focal segmental glomerulosclerosis
por: Shabaka, Amir, et al.
Publicado: (2022)

Fracaso renal agudo y síndrome nefrótico secundario a glomerulosclerosis segmentaria y focal asociada a COVID-19
por: Shabaka, Amir, et al.
Publicado: (2022)

Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
por: Melin, Jan, et al.
Publicado: (2021)

Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis
por: Ducloux, Didier, et al.
Publicado: (2021)

Humoral Response in Hemodialysis Patients Post-SARS-CoV-2 mRNA Vaccination: A Systematic Review of Literature
por: Notarte, Kin Israel, et al.
Publicado: (2023)

Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients
por: Becker, Matthias, et al.
Publicado: (2022)

Long‐term humoral immunity decline in hemodialysis patients following severe acute respiratory syndrome coronavirus 2 vaccination: A cohort study
por: Goggins, Eibhlin, et al.
Publicado: (2022)

Humoral Response to SARS-CoV-2 in Hemodialysis Patients
por: Steers, Nicholas J.
Publicado: (2021)

Humoral response to COVID-19 vaccination and maintenance hemodialysis: Correspondence
por: Mungmunpuntipantip, Rujititka, et al.
Publicado: (2023)

Prediction of humoral and cellular immune response to COVID-19 mRNA vaccination by TTV load in kidney transplant recipients and hemodialysis patients
por: Graninger, Marianne, et al.
Publicado: (2023)

Waning Humoral Response 6 Month after Double Vaccination with the mRNA-BNT162b2 Vaccine in Hemodialysis Patients
por: Balčiuvienė, Vilma, et al.
Publicado: (2023)

Humoral Immune Response Following SARS-CoV-2 mRNA Vaccination and Infection in Pediatric-Onset Multiple Sclerosis
por: Breu, Markus, et al.
Publicado: (2023)

Anxiety and depression in maintenance hemodialysis patients: prevalence and their effects on health-related quality of life
por: Nagy, Eman, et al.
Publicado: (2023)

Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients
por: Broseta, José Jesús, et al.
Publicado: (2021)

Humoral response to viral vector COVID-19 vaccine in hemodialysis patients
por: Raja, Niranjan, et al.
Publicado: (2022)

In vitro assessment of humoral immunity following exposure to heavy metals.
por: Koller, L D
Publicado: (1982)

Heterogeneity of the humoral immune response following Staphylococcus aureus bacteremia
por: Verkaik, N. J., et al.
Publicado: (2010)

Kinetics of the humoral response 1-year following vaccination with BNT162b2 SARS-CoV-2 vaccine among maintenance hemodialysis patients
por: Wand, Ori, et al.
Publicado: (2022)

Humoral immune response following prime and boost BNT162b2 vaccination in people living with HIV on antiretroviral therapy
por: Jedicke, Nils, et al.
Publicado: (2021)

Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination
por: Gonzalez-Perez, Maria, et al.
Publicado: (2022)

Humoral Response after Three Doses of mRNA-1273 or BNT162b2 SARS-CoV-2 Vaccines in Hemodialysis Patients
por: Broseta, José Jesús, et al.
Publicado: (2022)

Maintenance of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients after 1273-mRNA SARS-CoV-2 Vaccination
por: Gonzalez-Perez, Maria, et al.
Publicado: (2023)

Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination
por: Appelman, Brent, et al.
Publicado: (2021)

Humoral immune response following SARS-CoV-2 mRNA vaccination concomitant to anti-CD20 therapy in multiple sclerosis()
por: Novak, Frederik, et al.
Publicado: (2021)

Humoral and Cellular Response Following Vaccination With the BNT162b2 mRNA COVID-19 Vaccine in Patients Affected by Primary Immunodeficiencies
por: Amodio, Donato, et al.
Publicado: (2021)

Cellular and Humoral Responses Follow-up for 8 Months after Vaccination with mRNA-Based Anti-SARS-CoV-2 Vaccines
por: Gil-Manso, Sergio, et al.
Publicado: (2022)

SARS-CoV-2–reactive cellular and humoral immunity in hemodialysis population
por: Anft, Moritz, et al.
Publicado: (2021)

Impaired humoral immune response to hepatitis B vaccine in patients on maintenance hemodialysis
por: Mahallawi, Waleed H., et al.
Publicado: (2023)

Cellular and Humoral Immune Responses after Breakthrough Infection in Patients Undergoing Hemodialysis
por: Toda, Masataro, et al.
Publicado: (2023)

Suppression of Long-Lived Humoral Immunity Following Borrelia burgdorferi Infection
por: Elsner, Rebecca A., et al.
Publicado: (2015)

Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patients
por: Housset, Pierre, et al.
Publicado: (2022)

Spontaneous Splenic Rupture following Colorectal Surgery and Hemodialysis
por: AlMuhsin, Ahmed Mohammed, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ap6vivok4jiilrhm49l35b4u5o